Can Inflammatory Hematological Parameters be a Guide to Late-onset Fetal Growth Restriction?

Abstract

Purpose To compare the rates obtained from hematological parameters in cases of late-onset idiopathic fetal growth restriction (FGR) with healthy pregnancies and to evaluate the effect on neonatal outcomes.

Methods The study group consisted of 63 pregnant women with late-onset idiopathic FGR and the control group consisted of 91 healthy pregnant women. The determined rates were calculated from the control hemograms of patients at 28 weeks. Both groups were compared for neutrophil/lymphocyte ratio (NLR), platelet/lymphocyte ratio (PLR), and other parameters.

Results NLR, leukocyte and neutrophil levels were significantly higher in the FGR group (p<0.05). There was no significant difference in PLR, platelet and lymphocyte levels between the groups (p>0.05). To predict FGR, the best cut-off value of NLR was determined to be 4.11 with 56% sensitivity and 88% specificity values.

Conclusion Neutrophil, lymphocyte and platelet interactions have an important role in FGR development. Inflammation can be involved in the etiopathogenesis in late-onset FGR.

Keywords

Fetal growth restriction - inflammation - NLR - PLR - Apgar

Publikationsverlauf

Eingereicht: 02. März 2020

Angenommen: 03. Mai 2020

Artikel online veröffentlicht:
26. Juni 2020

• References

• 1 D’Silva A, Fyfe R, Hyett J. First trimester prediction and prevention of adverse pregnancy outcomes related to poor placentation. Curr Opin Obstet Gynecol 2017; 29: 367-374
• 2 Gordijn S, Beune I, Thilaganathan B. et al. Consensus definition of fetal growth restriction: a Delphi procedure. Ultrasound Obstet Gynecol 2016; 48: 333-339
• 3 Kalanithi LE, Illuzzi JL, Nossov VB. et al. Intrauterine growth restriction and placental location. J Ultrasound Med 2007; 26: 1481-1489
• 4 Karlı P, Özdemir AZ, Ayan D. Maternal serum and fetal cord blood C-reactive protein levels but not procalcitonin levels are increased in idiopathic intrauterine growth restriction. Med Sci Monit 2019; 25: 6512
• 5 Sharma D, Shastri S, Farahbakhsh N. et al. Intrauterine growth restriction–part 1. J Matern Fetal Neonatal Med 2016; 29: 3977-3987
• 6 Akgun N, Namli Kalem M, Yuce E. et al. Correlations of maternal neutrophil to lymphocyte ratio (NLR) and platelet to lymphocyte ratio (PLR) with birth weight. J Matern Fetal Neonatal Med 2017; 30: 2086-2091
• 7 Whitehead CL, McNamara H, Walker SP. et al. Identifying late-onset fetal growth restriction by measuring circulating placental RNA in the maternal blood at 28 weeks’ gestation. Am J Obstet Gynecol 2016; 214: 521.e1-521.e8
• 8 Heyborne KD, Witkin SS, McGregor JA. Tumor necrosis factor-α in midtrimester amniotic fluid is associated with impaired intrauterine fetal growth. Am J Obstet Gynecol 1992; 167: 920-925
• 9 Street ME, Seghini P, Fieni S. et al. Changes in interleukin-6 and IGF system and their relationships in placenta and cord blood in newborns with fetal growth restriction compared with controls. Eur J Endocrinol 2006; 155: 567-574
• 10 Bartha JL, Romero-Carmona R, Comino-Delgado R. Inflammatory cytokines in intrauterine growth retardation. Acta Obstet Gynecol Scand 2003; 82: 1099-1102
• 11 Al-Azemi M, Raghupathy R, Azizieh F. Pro-inflammatory and anti-inflammatory cytokine profiles in fetal growth restriction. Clin Exp Obstet Gynecol 2017; 44: 98-103
• 12 Kolaczkowska E, Kubes P. Neutrophil recruitment and function in health and inflammation. Nat Rev Immunol 2013; 13: 159-175
• 13 Kan O, Gemici A, Alkilic A. et al. The effect of preoperative neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio on predicting rupture risk in tubal ectopic pregnancies. Gynecol Obstet Invest 2019; 84: 378-382
• 14 Kirbas A, Ersoy AO, Daglar K. et al. Prediction of preeclampsia by first trimester combined test and simple complete blood count parameters. J Clin Diagn Res 2015; 9: QC20
• 15 Kan E, Emektar E, Corbacioglu K. et al. Evaluation of relationship between inflammatory markers and hyperemesis gravidarum in patients admitted to emergency department. Am J Emerg Med 2019;
• 16 Mei Z, Shi L, Wang B. et al. Prognostic role of pretreatment blood neutrophil-to-lymphocyte ratio in advanced cancer survivors: a systematic review and meta-analysis of 66 cohort studies. Cancer Treat Rev 2017; 58: 1-13
• 17 Okoye HC, Madu AJ, Korubo K. et al. Correlates of neutrophil/lymphocyte, platelet/lymphocyte, and platelet/neutrophil ratios of neonates of women with hypertensive disease of pregnancy with neonatal birth outcomes. Hypertens Pregnancy 2019; 38: 105-110
• 18 Nardozza LMM, Caetano ACR, Zamarian ACP. et al. Fetal growth restriction: current knowledge. Arch Gynecol Obstet 2017; 295: 1061-1077
• 19 Frøen JF, Gardosi JO, Thurmann A. et al. Restricted fetal growth in sudden intrauterine unexplained death. Acta Obstet Gynecol Scand 2004; 83: 801-807
• 20 Crovetto F, Triunfo S, Crispi F. et al. Differential performance of first-trimester screening in predicting small-for-gestational-age neonate or fetal growth restriction. Ultrasound Obstet Gynecol 2017; 49: 349-356
• 21 Laresgoiti-Servitje E. A leading role for the immune system in the pathophysiology of preeclampsia. J Leukoc Biol 2013; 94: 247-257
• 22 Serin S, Avcı F, Ercan O. et al. Is neutrophil/lymphocyte ratio a useful marker to predict the severity of pre-eclampsia?. Pregnancy Hypertens 2016; 6: 22-25
• 23 Cadden KA, Walsh SW. Neutrophils, but not lymphocytes or monocytes, infiltrate maternal systemic vasculature in women with preeclampsia. Hypertens Pregnancy 2008; 27: 396-405
• 24 Lurie S, Frenkel E, Tuvbin Y. Comparison of the differential distribution of leukocytes in preeclampsia versus uncomplicated pregnancy. Gynecol Obstet Invest 1998; 45: 229-231
• 25 Canzoneri BJ, Lewis DF, Groome L. et al. Increased neutrophil numbers account for leukocytosis in women with preeclampsia. Am J Perinatol 2009; 26: 729-732
• 26 Saftlas AF, Beydoun H, Triche E. Immunogenetic determinants of preeclampsia and related pregnancy disorders: a systematic review. Obstet Gynecol 2005; 106: 162-172
• 27 Laresgoiti-Servitje E, Gómez-López N, Olson DM. An immunological insight into the origins of pre-eclampsia. Hum Reprod Update 2010; 16: 510-524
• 28 Mannaerts D, Heyvaert S, De Cordt C. et al. Are neutrophil/lymphocyte ratio (NLR), platelet/lymphocyte ratio (PLR), and/or mean platelet volume (MPV) clinically useful as predictive parameters for preeclampsia?. J Matern Fetal Neonatal Med 2019; 32: 1412-1419
• 29 Özdemirci Ş, Başer E, Kasapoğlu T. et al. Predictivity of mean platelet volume in severe preeclamptic women. Hypertens Pregnancy 2016; 35: 474-482
• 30 Abo T, Kawamura T. Immunomodulation by the autonomic nervous system: therapeutic approach for cancer, collagen diseases, and inflammatory bowel diseases. Ther Apher 2002; 6: 348-357
• 31 Beksac MS, Fadiloglu E, Tanacan A. et al. A cut-off value for gestational week at birth for better perinatal outcomes in early- and late-onset fetal growth restriction. Z Geburtshilfe Neonatol 2019; 223: 289-296
• 32 Susilo SA, Pratiwi KN, Fattah AN. et al. Determinants of low APGAR score among preeclamptic deliveries in Cipto Mangunkusumo Hospital: a retrospective cohort study in 2014. Med J Indones 2015; 24: 183-189
• 33 Jaffar DW, Rabie MAF. Maternal platelet-to-lymphocyte ratio at delivery can predict poor neonatal outcome in preterm births. Turk J Obstet Gynecol 2018; 15: 254
• 34 Guven MA, Coskun A, Ertas IE. et al. Association of maternal serum CRP, IL-6, TNF-α, homocysteine, folic acid and vitamin b12 levels with the severity of preeclampsia and fetal birth weight. Hypertens Pregnancy 2009; 28: 190-200
• 35 Stout MJ, Cao B, Landeau M. et al. Increased human leukocyte antigen-G expression at the maternal–fetal interface is associated with preterm birth. J Matern Fetal Neonatal Med 2015; 28: 454-459
• 36 Leon-Garcia SM, Roeder HA, Nelson KK. et al. Maternal obesity and sex-specific differences in placental pathology. Placenta 2016; 38: 33-40
• 37 Bakrim S, Motiaa Y, Ouarour A. et al. Hematological parameters of the blood count in a healthy population of pregnant women in the Northwest of Morocco (Tetouan-M’diq-Fnideq provinces). Pan Afr Med J 2018; 29: 1-12